He has received honoraria for speaking and attended advisory planks with Bristol-Myers Squib, UCB celltech, Roche/Chugai, Pfizer, Abbvie, Merck, Mennarini, Sanofi-aventis, Eli-Lilly, Janssen, Novartis and Amgen

He has received honoraria for speaking and attended advisory planks with Bristol-Myers Squib, UCB celltech, Roche/Chugai, Pfizer, Abbvie, Merck, Mennarini, Sanofi-aventis, Eli-Lilly, Janssen, Novartis and Amgen. 18) with verified COVID-19 treated with tocilizumab no matter publication position. Our studies yielded a complete of 13 qualified content articles (treated with meropenemLuo, Continue Reading